Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer - PubMed (original) (raw)
Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer
M Anttila et al. J Clin Oncol. 1998 Aug.
Abstract
Purpose: To analyze alpha-catenin and collagen IV expression in epithelial ovarian cancer with special reference to their prognostic significance and correlations with clinical and pathologic characteristics, as well as cell proliferation marker Ki-67.
Patients and methods: Alpha-catenin, collagen IV, and Ki-67 expression was immunohistochemically analyzed in paraffin-embedded specimens of 316 patients with epithelial ovarian cancer.
Results: Alpha-catenin and collagen IV expression was not interrelated or related to International Federation of Gynecology and Obstetrics (FIGO) stage or proliferation marker Ki-67. Alpha-catenin expression was reduced (< 100%) in 50% of primary tumors. Reduced alpha-catenin and collagen IV expression was directly related to high histologic grade (P < .001). In both univariate and multivariate analyses, Ki-67 proliferation significantly predicted overall survival. In the subset of 86 patients with stage I tumor, a reduced (< 100%) alpha-catenin expression approached statistical significance as a negative prognostic factor (P = .035) and retained its statistical significance in the multivariate analysis (P = .025). The low (< 30%) expression of alpha-catenin (n = 10) was a sign of inferior survival as compared with normal expression in both the univariate (P = .0107) and multivariate analyses (P = .0105).
Conclusion: Alpha-catenin expression seems to be a useful marker of those FIGO stage I tumors likely to run a less favorable course. The high cell proliferative activity was associated with poor survival. In the future, alpha-catenin and Ki-67 expression should be studied in a large prospective cohort that includes early-stage cancers to select the more aggressive tumors for intense early chemotherapy.
Similar articles
- Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
Voutilainen KA, Anttila MA, Sillanpää SM, Ropponen KM, Saarikoski SV, Juhola MT, Kosma VM. Voutilainen KA, et al. J Clin Pathol. 2006 May;59(5):460-7. doi: 10.1136/jcp.2005.029876. Epub 2006 Feb 3. J Clin Pathol. 2006. PMID: 16461565 Free PMC article. - Prognostic significance of p53 immunostaining in epithelial ovarian cancer.
Hartmann LC, Podratz KC, Keeney GL, Kamel NA, Edmonson JH, Grill JP, Su JQ, Katzmann JA, Roche PC. Hartmann LC, et al. J Clin Oncol. 1994 Jan;12(1):64-9. doi: 10.1200/JCO.1994.12.1.64. J Clin Oncol. 1994. PMID: 8270986 - Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Salvesen HB, Iversen OE, Akslen LA. Salvesen HB, et al. Clin Cancer Res. 1998 Nov;4(11):2779-85. Clin Cancer Res. 1998. PMID: 9829742 - Contribution of immunohistochemistry in prognostic assessment of epithelial ovarian carcinoma --review of the literature I.
Tomsová M, Melichar B. Tomsová M, et al. Acta Medica (Hradec Kralove). 2006;49(3):161-5. Acta Medica (Hradec Kralove). 2006. PMID: 17117604 Review. - Biologic prognostic factors in ovarian cancer: a review.
Framarino dei Malatesta ML, Veneziano M, Peppicelli M, Lanzi G, Marzetti L. Framarino dei Malatesta ML, et al. Eur J Gynaecol Oncol. 1998;19(2):123-5. Eur J Gynaecol Oncol. 1998. PMID: 9611049 Review.
Cited by
- Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
Voutilainen KA, Anttila MA, Sillanpää SM, Ropponen KM, Saarikoski SV, Juhola MT, Kosma VM. Voutilainen KA, et al. J Clin Pathol. 2006 May;59(5):460-7. doi: 10.1136/jcp.2005.029876. Epub 2006 Feb 3. J Clin Pathol. 2006. PMID: 16461565 Free PMC article. - Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.
Pirinen RT, Hirvikoski P, Johansson RT, Hollmén S, Kosma VM. Pirinen RT, et al. J Clin Pathol. 2001 May;54(5):391-5. doi: 10.1136/jcp.54.5.391. J Clin Pathol. 2001. PMID: 11328840 Free PMC article. - beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome.
Gamallo C, Palacios J, Moreno G, Calvo de Mora J, Suárez A, Armas A. Gamallo C, et al. Am J Pathol. 1999 Aug;155(2):527-36. doi: 10.1016/s0002-9440(10)65148-6. Am J Pathol. 1999. PMID: 10433945 Free PMC article. - Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.
Li H, Cai Q, Godwin AK, Zhang R. Li H, et al. Mol Cancer Res. 2010 Dec;8(12):1610-8. doi: 10.1158/1541-7786.MCR-10-0398. Epub 2010 Nov 29. Mol Cancer Res. 2010. PMID: 21115743 Free PMC article. - Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination.
Fujimoto H, Yoshihara M, Rodgers R, Iyoshi S, Mogi K, Miyamoto E, Hayakawa S, Hayashi M, Nomura S, Kitami K, Uno K, Sugiyama M, Koya Y, Yamakita Y, Nawa A, Enomoto A, Ricciardelli C, Kajiyama H. Fujimoto H, et al. Cancer Metastasis Rev. 2024 Sep;43(3):1037-1053. doi: 10.1007/s10555-024-10169-8. Epub 2024 Mar 28. Cancer Metastasis Rev. 2024. PMID: 38546906 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous